We report here the isolation of a cDNA clone containing the full coding region of bovine phenylethanolamine N-methyltransferase (PNMTase, EC 2.1.1.28, S-adenosyl-Lmethionine:phenylethanolamine N-methyltransferase). The complete nucleotide sequence of the cDNA has been determined, and the amino acid sequence of PNMTase deduced. Cultured cells transfected with an expression vector containing this cDNA produced high levels of PNMTase enzymatic activity. Antibodies specific for tyrosine hydroxylase [EC 1.14.16.2, tyrosine 3-monooxygenase; L-tyrosine, tetrahydrobiopterine: oxygen oxidoreductase (3-hydroxylating)], the first enzyme in the catecholamine pathway, possess a striking affinity for the PNMTase protein synthesized in vitro. Comparison of the deduced amino acid sequence of bovine PNMTase to rat tyrosine hydroxylase reveals that PNMTase shares significant homology with tyrosine hydroxylase and supports previous protein and immunological data suggesting that the catecholamine biosynthetic enzymes are structurally related.
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The catecholamine biosynthetic pathway is composed offour enzymes responsible for the enzymatic conversion of the amino acid tyrosine to the three principal catecholamine compounds dopamine, norepinephrine, and epinephrine (1) . Phenylethanolamine N-methyltransferase (PNMTase; EC 2.1.1.28; S-adenosyl-L-methionine:phenylethanolamine Nmethyltransferase) is the terminal enzyme in the catecholamine pathway, catalyzing the synthesis of epinephrine from norepinephrine (2) . The enzyme is present in high levels in the chromaffin cells of the adrenal medulla, where epinephrine serves as a hormone (3) . Sympathetic ganglia contain a minor population of small intensely fluorescent cells (SIF cells), which contain PNMTase catalytic activity and synthesize ephinephrine (4) (5) (6) . This is reminiscent of the adrenal medulla in that two catecholaminergic cell types exist within a specific population of cells producing norephinephrine and epinephrine as their final transmitter products. PNMTase is also found in neuronal perikarya of the medulla oblongata, hypothalamus, and retina where epinephrine is presumed to function as a neurotransmitter (7) (8) (9) (10) (11) (12) (13) .
We have generated molecular probes to the catecholamine enzymes as a means to further investigate their expression at the mRNA level as well as to characterize the genes coding for these proteins. It has been suggested that the catecholamine enzymes are related to one another not ohly as sequential enzymes in a biosynthetic pathway but also as proteins sharing immunological and structural similarities (14) (15) (16) .
To obtain information about the structure of the PNMTase molecule and to further defie the extent of the evolutionary relationships among these enzymes, a full-length cDNA clone to PNMTase mRNA was isolated, and the entire nucleotide and amino acid sequences were determined. We show that this PNMTase cDNA is capable of programming the in vitro synthesis of PNMTase that is both enzymatically active and extremely cross reactive with antisera against tyrosine hydroxylase [TyrHase; EC 1.14.16.2.; tyrosine 3-monooxygenase; L-tyrosine tetrahydrobiopterine: oxygen oxidoreductase (3-hydroxylating)]. These antigenic similarities are further revealed by comparison of the deduced amino acid sequences of TyrHase and PNMTase.
MATERIALS AND METHODS
Isolation of PNMTase cDNA Clone. Polysomal poly(A)+ mRNA was prepared from bovine adrenal medulla by a modification of the procedure of Holbrook and Brown (17) as described (18) . A Xgtll expression library was constructed as described in detail elsewhere (19) . Approximately 120,000 phage plaques were transferred to nitrocellulose and screened by hybridization with a 32P-labeled .
Plaque-purified clones were restriction mapped and sequenced by the chemical modification method of Maxam and Gilbert (21) . Detailed methods for nick-translation, library construction, and screening are described in Maniatis et al. (22) .
Metallothionein PNMTase Expression Vector and Cell Transfection. PNMTase-17 cDNA was ligated in both orientations behind the mouse metallothionein (MT)-I promoter (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) , see Fig. 2A . The plasmid expression vector, pNUT (B. Davison, personal communication), also contains a cDNA encoding the mutant form of dihydrofolate reductase (28) , driven by the simian virus 40 promoter. The MTPNMTase construct was transfacted into the baby hamster kidney cell line (BHK) (29) , using standard CaPO4 precipitation procedures (26, 30) . Cell lines, which had stably incorporated the plasmid, were selected by including methotrexate to a final concentration of 1 mM in the culture media.
Transcription at the heavy metal responsive MT-I promoter was induced by adding ZnSO4 to the culture media at a final concentration of 100 ,AM (26) . Cells were harvested after a 16-hr incubation, and the cell pellets were sonicated in 200 A.l of homogenization buffer (10 mM potassium phosphate, pH 7.0/0.2% Triton X-100) and centrifuged for 10 min in an Eppendorf centrifuge. Supernatants were immediately frozen at -70'C or assayed directly for PNMTase enzyme activity (18) .
In (22) . The purified mRNA was translated at a final concentration of 100 Ag/ml, using the conditions described above. Complete translation reactions were incubated with specific antisera, fractionated by NaDodSO4/PAGE, and analyzed by fluorography.
RESULTS AND DISCUSSION
cDNA Cloning and DNA Sequencing. A cDNA expression library containing approximately 107 recombinants was constructed in Xgtll (36) Mr 31,000 determined by NaDodSO4 gel electrophoresis of the purified enzyme.
MT-PNMTase Expression. As shown in Fig. 2A , the PNMTase-17 cDNA has been inserted downstream from the mouse MT-I promoter element in an expression vector containing the selectable marker gene dihydrofolate reductase. Following transfection into BHK cells and selection in methotrexate containing media, transformed cell lines were isolated containing stable integrants of the MT-PNMTase construct. Extracts made from these cell lines were assayed for the ability to N-methylate phenylethanolamine using the cofactor S-adenosyl-L-[3H]methionine in a PNMTase enzyme assay. As shown in Fig. 2B, bar 1 In Vitro Transcription and Translation. We (15) , and others (16) , have demonstrated that antibodies specific for a single, purified catecholamine biosynthetic enzyme appear to recognize more than one catecholamine enzyme from in vitro translated protein products. The most unusual example of this cross reactivity was the ability of the antibody to the trypsin-digested form of TyrHase (tTyrHase) (32) to precipitate primarily PNMTase from in vitro translation products.
As shown in Fig. 3A , lane 1, antibody to rat PNMTase precipitates a Mr 31,000 protein, identical in size to that found in vivo (18) . When specific antisera raised against tTyrHase is incubated with bovine adrenal mRNA translation products, a similar Mr 31,000 protein is precipitated (Fig. 3A, lane 3) . Although immunoblot analysis, enzymatic inhibition studies, and immunocytochemical localizations have confirmed that this antiserum is absolutely specific for purified TyrHase (32, (40) (41) (42) (43) tTyrHase antibody to precipitate the Mr 31,000 protein, indicating that this protein is indeed PNMTase (Fig. 3A, lane  2) . Conversely, when excess tTyrHase antibody is used to preadsorb the translation mixture, the PNMTase antibody no longer precipitates PNMTase (Fig. 3A, lane 4) . These results show that newly synthesized PNMTase is readily recognized by an antibody that is very specific for purified TyrHase. This occurs in spite of the correspondingly high level of translatable TyrHase mRNA present but does not occur when antibody raised against the holoenzyme of TyrHase (Mr 60,000 subunit) is used (15) .
The availability of the full-length PNMTase-17 cDNA clone isolated here has allowed us to examine this cross reactivity in isolation, using an in vitro SP6 system coupling PNMTase-17 transcription and translation. The full-length PNMTase-17 cDNA insert was subcloned into an SN plasmid vector (43) . RNA was transcribed from the linearized SP6.PNMTase-17 DNA template using SPN polymerase as described (43) , and the resultant transcripts were used to program an in vitro translation system. As shown in lanes 1 and 2 of Fig. 3B Fig. 4 . The most significant homologies become apparent when the entire PNMTase sequence is aligned either with the amino-terminal 218 amino acids or TyrHase (Fig. 4A) , or with the carboxyl-terminal 264-454 amino acids of TyrHase (Fig.  4B) Sequence homologies have also been reported for sequential enzymes in ketoadipate biosynthesis, a multienzyme pathway for the metabolism of catechol and protocatechuate substrates in bacteria (45) . Comparisons of the aminoterminal sequences of the enzymes that mediate sequential metabolic steps in this pathway reveals an overall homology of 30% (46) . Enzymes catalyzing reactions separated by one or two metabolic steps in this pathway show regions of 21 and 38 residues exhibiting identities of 36% and 31%, respectively (47, 48) . Furthermore, antisera raised against an individual enzyme in the pathway cross react with other enzymes in the same pathway (47) .
In yet another Escherichia coli multienzyme pathway, that for the biosynthesis of threonine and methionine, the first and the third enzymes share interspersed sequence homologies analogous to those reported in our study. Specifically, regions of approximately 130 and 250 amino acid residues have been identified in these two enzymes that possess overall homologies of 20-50% (49) .
Because PNMTase is an integral component in epinephrine biosynthesis, analysis of its structure can be expected to lend insights into the enzymatic and regulatory mechanisms involved in this process. It Future studies defining the three-dimensional structures of both proteins and establishing the relationship of these regions to their functional aspects may more clearly elucidate the mechanisms by which these enzymes evolved.
